Parker Waichman LLP is already representing dozens of plaintiffs in Plavix bleeding lawsuits the firm filed this year in the Supreme Court of the State of New York, County of New York.
New York, NY (PRWEB) April 13, 2012
Parker Waichman LLP, a national law firm representing people injured by defective drugs, is investigating lawsuit claims on behalf of people who allegedly suffered severe bleeding side effects as a result of Plavix, a blood thinner made by Bristol -Myers Squibb Company and Sanofi-Aventis U.S., L.L.C. Parker Waichman LLP is already representing dozens of plaintiffs in Plavix bleeding lawsuits the firm filed this year in the Supreme Court of the State of New York, County of New York. Those complaints include a wrongful death lawsuit brought on behalf of the estate of a Mississippi woman who suffered a fatal gastrointestinal hemorrhage while taking Plavix (Index No. 150388/2012). Parker Waichman LLP is also representing the estate of a man from Washington State who suffered a cerebral hemorrhage and died after using Plavix (No. 101832/2012).
Possible Plavix bleeding side effects being investigated by Parker Waichman LLP include:
- Gastrointestinal bleeding
- Cerebral hemorrhage
- Internal bleeding
- Bone marrow damage
- Thrombotic Thrombocytopenic Purpura (TTP)
- Heart attack
Plavix, a blood thinner known generically as clopidogrel, was first approved by the U.S. Food and Drug Administration (FDA) in 1997 for the prevention of heart attack and stroke. According to the Plavix lawsuits filed by Parker Waichman LLP, the drug’s makers falsely touted Plavix as being more effective and safer in reducing the risk of ischemic events compared to a less expensive daily aspirin regimen. By 2005, Plavix was the sixth top selling drug in the U.S. and the Defendants enjoy annual sales of Plavix totaling 3.8 billion dollars, the complaints state.
In 2003, the stroke prevention study conducted by the National Institute of Neurological Disorders and Stroke found that combination aspirin-Plavix therapy may significantly increase the risk of life-threatening bleeding. Of the 3,000 participants followed by the study, 6.5% with the Plavix-aspirin combination experienced an adverse bleeding event. By comparison, 3.3% of those who took aspirin alone developed similar bleeding symptoms. The study also found that the combination therapy was responsible for a death rate of 5.8%. [nlm.nih.gov/databases/alerts/2011_ninds_stroke.html]
A more recent study, published in the New England Journal of Medicine in April 2006, found that, "Overall, clopidogrel plus aspirin was not significantly more effective than aspirin alone in reducing the rate of myocardial infarction, stroke, or death from cardiovascular causes." [nejm.org/doi/full/10.1056/NEJMoa060989]
Plavix bleeding side effects are discussed in more detail in this video blog produced by Parker Waichman LLP.
Parker Waichman LLP continues to offer free legal consultations to victims of Plavix side effects. If you or a loved one experienced serious, life-threatening or fatal internal bleeding, heart attacks, strokes, or a blood disorder, and you believe Plavix is to blame, please contact their office by visiting the firm's Plavix side effects page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
For more information regarding Plavix side effects lawsuits and Parker Waichman LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Herbert Waichman, Partner